Centrum Medyczne ENEL-MED S.A. (WSE:ENE)
Poland · Delayed Price · Currency is PLN 20.20
-0.20 (-0.98%)
Oct 15, 2026, 1:28 PM CET
Centrum Medyczne ENEL-MED Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 571 | 486 | 571 | 537 | 444 | 501 | |
Market Cap Growth | 9.19% | -14.85% | 6.32% | 21.02% | -11.30% | 32.75% |
Enterprise Value | 899 | 762 | 814 | 762 | 639 | 711 |
Last Close Price | 20.40 | 17.20 | 20.20 | 19.00 | 15.70 | 17.70 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.24 | 37.73 | 39.10 | 67.78 | - | - |
Forward PE | - | 190.77 | 190.77 | 190.77 | 190.77 | 190.77 |
PS Ratio | 0.63 | 0.57 | 0.78 | 0.87 | 0.90 | 1.14 |
PB Ratio | 2.99 | 2.62 | 3.31 | 3.40 | 2.92 | 2.85 |
P/TBV Ratio | 3.36 | 2.95 | 3.77 | 3.93 | 3.37 | 3.12 |
P/FCF Ratio | 30.34 | 15.22 | 9.79 | 9.74 | - | 17.54 |
P/OCF Ratio | 4.72 | 4.44 | 5.53 | 6.11 | 11.09 | 7.45 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.98 | 0.89 | 1.11 | 1.24 | 1.29 | 1.61 |
EV/EBITDA Ratio | 9.37 | 13.13 | 15.92 | 25.73 | 115.66 | 28.69 |
EV/EBIT Ratio | 26.07 | 33.00 | 35.57 | 217.67 | - | 345.79 |
EV/FCF Ratio | 47.57 | 23.85 | 13.96 | 13.82 | - | 24.92 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.88 | 1.84 | 1.59 | 1.70 | 1.44 | 1.17 |
Debt / EBITDA Ratio | 3.76 | 3.26 | 2.80 | 3.56 | 5.14 | 3.44 |
Debt / FCF Ratio | 19.09 | 10.69 | 4.71 | 4.87 | - | 7.18 |
Net Debt / Equity Ratio | 1.69 | 1.65 | 1.37 | 1.53 | 1.26 | 0.72 |
Net Debt / EBITDA Ratio | 6.58 | 5.28 | 4.62 | 8.18 | 34.67 | 5.13 |
Net Debt / FCF Ratio | 17.22 | 9.58 | 4.05 | 4.39 | -32.49 | 4.46 |
Asset Turnover | 1.50 | 1.45 | 1.41 | 1.31 | 1.14 | 1.06 |
Inventory Turnover | 198.28 | 175.20 | 154.96 | 150.00 | 148.00 | 108.90 |
Quick Ratio | 0.61 | 0.46 | 0.55 | 0.35 | 0.50 | 1.05 |
Current Ratio | 0.64 | 0.61 | 0.66 | 0.40 | 0.57 | 1.12 |
Return on Equity (ROE) | 9.12% | 7.19% | 8.83% | 5.11% | -14.38% | -1.03% |
Return on Assets (ROA) | 3.54% | 2.46% | 2.74% | 0.47% | -2.83% | 0.31% |
Return on Invested Capital (ROIC) | 5.46% | 4.05% | 4.32% | 0.84% | -6.09% | -9.65% |
Return on Capital Employed (ROCE) | 7.00% | 4.90% | 5.60% | 1.00% | -6.00% | 0.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.92% | 2.65% | 2.56% | 1.47% | -5.31% | -0.28% |
FCF Yield | 3.30% | 6.57% | 10.21% | 10.27% | -1.33% | 5.70% |
Buyback Yield / Dilution | - | - | - | - | -17.55% | -2.08% |